<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The non-competitive <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> (<z:chebi fb="0" ids="31882">NMDA</z:chebi>) <z:chebi fb="68" ids="48706">antagonist</z:chebi>, MK-801, has been reported to prevent or attenuate ischemic brain damage in various animal models </plain></SENT>
<SENT sid="1" pm="."><plain>In <z:chebi fb="2" ids="5615">halothane</z:chebi>-anesthetized gerbils it was found that an optimal dose of MK-801 (3.0 mg/kg) for providing cerebral protection also produced <z:hpo ids='HP_0002045'>hypothermia</z:hpo> (31.1 +/- 0.62 degrees C) relative to control animals (34.2 +/- 0.77 degrees C, P less than 0.01) </plain></SENT>
<SENT sid="2" pm="."><plain>This degree of <z:hpo ids='HP_0002045'>hypothermia</z:hpo> alone was sufficient to provide complete histological and functional protection (spatial memory) against 5 min of carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>In gerbils made ischemic, but maintained at <z:mpath ids='MPATH_458'>normal</z:mpath> body temperature, a dose of 3.0 mg/kg of MK-801 provided no protection against hippocampal cell loss or spatial <z:hpo ids='HP_0002354'>memory impairment</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>These data suggest that the protective actions of MK-801 may be due entirely to drug-induced <z:hpo ids='HP_0002045'>hypothermia</z:hpo> </plain></SENT>
</text></document>